From CAR-T’s Launch, Payers vs. Gene Therapy & Photos From “What’s Hot”:

What's Hot in Boston Biotech 2018
What’s Hot in Boston Biotech 2018

Insurers have been preparing for the arrival of gene therapy, but a lot of work has to be done for the U.S. healthcare system to successfully adapt. Harvard Pilgrim Health Care chief medical officer Michael Sherman (2nd from right) says we “need to solve for the budget impact” of gene therapies as more and more come to market, or risk situations in which patients who should get treated don’t get access.